Authors: Carraresi, L Tripodi, SA Mulder, LCF Bertini, S Nuti, S Schuerfeld, K Cintorino, M Bensi, G Rossini, M Mora, M

Citation: L. Carraresi et al., Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes, ONCOGENE, 20(56), 2001, pp. 8148-8153

Authors: Greer, CE Petracca, R Buonamassa, DT Di Tommaso, A Gervase, B Reeve, RL Ugozzoli, M Van Nest, G De Magistris, MT Bensi, G

Citation: Ce. Greer et al., The comparison of the effect of LTR72 and MF59 adjuvants on mouse humoral response to intranasal immunisation with human papillomavirus type 6b (HPV-6b) virus-like particles, VACCINE, 19(9-10), 2000, pp. 1008-1012

Authors: Heile, JM Fong, YL Rosa, D Berger, K Saletti, G Campagnoli, S Bensi, G Capo, S Coates, S Crawford, K Dong, C Wininger, M Baker, C Cousens, L Chien, D Ng, P Archangel, P Grandi, G Houghton, M Abrignani, S

Citation: Jm. Heile et al., Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates, J VIROLOGY, 74(15), 2000, pp. 6885-6892

Authors: Patoia, L Del Favero, A Giglietti, A Malacarne, P Donati, D Indelli, M Bensi, G Palladino, MA Cigarini, P Kempe, R Voigt, T

Citation: L. Patoia et al., Intravenous itasetron: Establishing the effective dose range for the prophylactic control of acute emesis in cancer patients undergoing high-dose cisplatin chemotherapy, CL ONCOL-UK, 11(2), 1999, pp. 99-104